Marburg | Global Biodefense

Menu

Latest stories

Biosurveillance and Biosecurity Capacity Building in Africa

U.S. Supporting Ecological Surveillance for Special Pathogens in Sierra Leone

DARPA BTO EZ BAA

Fundamental Research to Counter Biological, Chemical, and Nuclear Weapons

More on pathogens and preparedness

WHO Updates Blueprint List of Priority Diseases

by Global Biodefense February 12, 2018, 5:51 pm
Inhibiting PP2A-B56 to Suppress Ebola Virus Transcription and Infection

by Global Biodefense January 22, 2018, 8:56 pm
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures
NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses

by Global Biodefense October 10, 2017, 3:24 pm
Monoclonal Antibody Cures Late-Stage Marburg Infection in Monkeys

by Global Biodefense April 6, 2017, 6:26 am
PHEMCE Review: Accomplishments and Future Areas of Opportunity

by Rebecca Fish March 2, 2017, 8:37 am
GAO Recommendations on Select Agent Program Improvements
Advanced Development of Filovirus and Lassa Fever Vaccines

by Global Biodefense March 13, 2016, 4:01 pm
A Lengthy Arms Race Between Ebola and Bats

by Global Biodefense December 23, 2015, 11:39 am
USAMRIID Seeks Mouse Supply for Filovirus Research

by Global Biodefense December 22, 2015, 11:35 am
DoD CBRN Medical Countermeasure Consortium
Handicapping Ebola to Buy Immune System Time to Respond

by Global Biodefense November 2, 2015, 9:24 am

Congratulations. You've reached the end of the internet.

Back to Top